Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03426384 · ClinicalTrials.gov registry record · NA
FLARE Lupus Research Study Systemic Lupus Erythematosus
A NA study of System; Lupus Erythematosus, sponsored by Mymee.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03426384 is a NA study of System; Lupus Erythematosus that has completed, run by Mymee. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03426384, a NA study of System; Lupus Erythematosus, has completed, sponsored by Mymee.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE. The second phase will assess changes in healthcare utilization and cost over a one year period after program end.
Conditions Studied
Interventions
- BEHAVIORAL Mymee Program
Study Locations (1)
New York
- Mymee Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2019-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03426384
The ClinicalTrials.gov registry entry for NCT03426384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mymee, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with System; Lupus Erythematosus appearing as the primary indexed condition, and to 1 intervention - of which Mymee Program is the first listed.
NCT03426384 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03426384 about?
NCT03426384 is a clinical study titled "FLARE Lupus Research Study Systemic Lupus Erythematosus". The first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE. The second phase will assess changes in healthcare utilization and cost over a one year period after program end.
What is the current status of trial NCT03426384?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-02-12. Estimated completion is 2019-12-05.
What conditions does trial NCT03426384 study?
This clinical trial studies the following conditions: System; Lupus Erythematosus.
What interventions are being tested in trial NCT03426384?
The interventions under investigation include: Mymee Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03426384?
This trial is sponsored by Mymee, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03426384 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.